HomeCompareAIQUY vs KMB

AIQUY vs KMB: Dividend Comparison 2026

AIQUY yields 1.75% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $11.9K in total portfolio value
10 years
AIQUY
AIQUY
● Live price
1.75%
Share price
$41.50
Annual div
$0.73
5Y div CAGR
29.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.0K
Annual income
$3,492.07
Full AIQUY calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — AIQUY vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAIQUYKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AIQUY + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AIQUY pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIQUY
Annual income on $10K today (after 15% tax)
$148.84/yr
After 10yr DRIP, annual income (after tax)
$2,968.26/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, KMB beats the other by $1,461.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIQUY + KMB for your $10,000?

AIQUY: 50%KMB: 50%
100% KMB50/50100% AIQUY
Portfolio after 10yr
$39.9K
Annual income
$4,351.70/yr
Blended yield
10.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

AIQUY
Analyst Ratings
4
Buy
1
Sell
Consensus: Buy
Altman Z
4.8
Piotroski
5/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIQUY buys
2
KMB buys
0
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$AIQUY▼ Sell$1,001 - $15,0002024-06-21
Daniel Goldman🏢 House$AIQUY▼ Sell$15,001 - $50,0002023-07-10
Peter Meijer🏢 House$AIQUY▼ Sell$1,001 - $15,0002021-02-17
Greg Gianforte🏢 House$AIQUY▲ Buy$15,001 - $50,0002020-08-05
Greg Gianforte🏢 House$AIQUY▲ Buy$15,001 - $50,0002020-08-04
Greg Gianforte🏢 House$AIQUY▼ Sell$15,001 - $50,0002020-01-13
Donna Shalala🏢 House$AIQUY▼ Sell$1,001 - $15,0002019-06-24
Greg Gianforte🏢 House$AIQUY▼ Sell$100,001 - $250,0002019-03-21
Donna Shalala🏢 House$AIQUY▼ Sell$1,001 - $15,0002019-03-19
Donna Shalala🏢 House$AIQUY▼ Sell$1,001 - $15,0002019-03-18
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAIQUYKMB
Forward yield1.75%5.25%
Annual dividend / share$0.73$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29.1%17%
Portfolio after 10y$34.0K$45.9K
Annual income after 10y$3,492.07$5,211.33
Total dividends collected$12.1K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: AIQUY vs KMB ($10,000, DRIP)

YearAIQUY PortfolioAIQUY Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$10,926$226.06$11,314$613.68$388.00KMB
2$11,989$298.01$12,865$759.19$876.00KMB
3$13,223$394.53$14,709$943.96$1.5KKMB
4$14,673$525.01$16,919$1,180.17$2.2KKMB
5$16,403$702.94$19,588$1,484.33$3.2KKMB
6$18,500$948.12$22,838$1,879.06$4.3KKMB
7$21,085$1,290.15$26,832$2,395.60$5.7KKMB
8$24,335$1,774.14$31,788$3,077.63$7.5KKMB
9$28,509$2,470.53$38,000$3,986.82$9.5KKMB
10$33,997$3,492.07$45,872$5,211.33$11.9KKMB

AIQUY vs KMB: Complete Analysis 2026

AIQUYStock

L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa. The company's Gas & Services segment offers oxygen, nitrogen, argon, hydrogen, and carbon monoxide to the metals, chemicals, refining, and energy sectors; and gases, application equipment, and associated services to the materials and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, and craftsmen and retail sectors. It also supplies medical gases, hygiene products, equipment, and services to hospitals, as well as to patients in their homes; and produces and distributes healthcare specialty ingredients for the cosmetics, pharmaceutical, and vaccine markets. In addition, this segment supplies gases, materials, and services for use in the production of semi-conductors, as well as flat screens and photovoltaic panels. Its Engineering & Construction segment designs, develops, and builds industrial gas production plants for third parties; and designs and manufactures plants in the traditional, renewable, and alternative energy sectors. The company's Global Markets & Technologies segment delivers technological solutions, such as molecules, equipment, and services to support the markets of energy transition, primarily in transport, energy, and waste valorization, as well as related to deep tech in the space exploration, aerospace, and big science. This segment also invests in biomethane production units, as well as develops stations for distributing natural bio-gas for vehicles and hydrogen to support clean mobility; operates biomethane production units for use in the maritime industry; and supplies gases for the offshore oil and gas platforms, offshore wind turbines, and cryogenic transportation by sea. L'Air Liquide S.A. was incorporated in 1902 and is headquartered in Paris, France.

Full AIQUY Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this AIQUY vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIQUY vs SCHDAIQUY vs JEPIAIQUY vs OAIQUY vs KOAIQUY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.